About
Pharmaceutical industry executive with 20+ years of experience across large pharma and biotech startups. Former Head of Search and Evaluation at MSD, co-founder and CEO of reViral (acquired by Pfizer), and NED on the board of Guard Therapeutics. Holds a PhD in Biochemistry from King's College London and an MBA.
Experience
- XGEN VentureVenture Partnercurrent2025 — present
- Guard TherapeuticsNon Executive Board Membercurrent2024 — presentStockholm County, Sweden
- MSDHead of Search and Evaluation BD&L, Europe a2021 — 2025London Area, United Kingdom
- MSDHead of Search and Evaluation, European BD&L team2021 — 2025
- MSDExecutive Director, Oncology BD&L, Europe2015 — 2021
- ReViralCEO and co-founder2011 — 2015
- Khatereh Consultancy LtdFounder, Director2010 — 2015
- NexGenix PharmaceuticalsDirector of BD (Consultant)2010 — 2011
- Eurand SPASenior Licensing2009 — 2011
- Biotechnology CompaniesBD Consultant to Biotech Companies2008 — 2009
- PiramedHead of Business Development2003 — 2008
- Ludwig Institute for Cancer ResearchScientific Programme Manager1996 — 2003
Skills & more
BiotechnologyR&D9Technology Transfer24Pharmaceutical Industry40Clinical Development13Lifesciences16Drug Discovery25Oncology36Drug Development19Clinical Trials8Molecular Biology9Biomarkers4
+3 more
BiopharmaceuticalsCommercializationLicensingLanguages English · French · Italian · Persian
From Khatereh's professional profile.
Colleagues at XGEN Venture
Bastiaan van der Baan
Venture Partner at XGEN Venture
Bertil Lindmark
Venture Partner at XGEN Venture
Bianca Benatti
Jr. Analyst at XGEN Venture
Carlotta Marchese
Regulatory and Corporate Affairs Specialist at XGEN Venture
Daniele Scarinci
Founder and Managing Partner at XGEN Venture
Federica Draghi
Founder and Managing Partner at XGEN Venture
Gokhan Batur
Venture Partner at XGEN Venture
Graziano Piredda
Sr. Analyst at XGEN Venture
Frequently asked questions
- Who is Khatereh Ahmadi?
- Pharmaceutical industry executive with 20+ years of experience across large pharma and biotech startups. Former Head of Search and Evaluation at MSD, co-founder and CEO of reViral (acquired by Pfizer), and NED on the board of Guard Therapeutics. Holds a PhD in Biochemistry from King's College London and an MBA.
- Where does Khatereh Ahmadi work?
- Khatereh Ahmadi is Venture Partner at XGEN Venture.
- Where did Khatereh Ahmadi go to school?
- Khatereh Ahmadi studied at Henley Business School (Executive MBA, Business); King's College London (PhD, Biochemistry).
Same school
Also attended Henley Business School35
John HortonInvestor at DN CapitalIrene ArdenstedtInvestor at Luminar VenturesCharles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures AgSanne van ErpInvestment manager at NoaberKieran MudryyPartner at 4BIO CapitalDavid LeftleyCo Founder & CTO at Bloc Ventures
+ 29 more
Also attended King's College London233
Harry StebbingsFounder & General Partner at 20VCDominic JacquessonInvestor at Index VenturesJohn HortonInvestor at DN CapitalBob ThomasPartner at OxxKatherineHealthcare Investment Lead at Hummingbird VenturesÖzge Gizem YerlikayaGeneral Counsel at Idacapital
.avif)
+ 227 more
Shared employers
Also worked at Guard Therapeutics2
Also worked at MSD8
Hiroshi TamadaChief Medical Officer at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesSofia HasselbergInvestment Director at Bonnier CapitalMichelle HohmannSenior HR Manager & Recruiter at Apollo Health VenturesMirjam Mol-ArtsAdvisory Committee member at Curie CapitalPriya AgrawalMSD at i3 — Investing in Innovation Africa
/https%3A%2F%2Fbonniercapital.se%2Fwp-content%2Fuploads%2F2023%2F02%2FSofia-3.jpg)
+ 2 more
